Le Lézard
Classified in: Health, Science and technology
Subject: MRR

Cell Free Protein Expression Global Market Report 2022: Featuring Bioneer, GeneCopoeia, New England Biolabs & More


DUBLIN, Dec. 1, 2022 /PRNewswire/ -- The "Cell Free Protein Expression Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2022 to 2030" report has been added to  ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

For decades, cell free protein expression method has been used for analysis of proteins. The most commonly used lysate include wheat germ or reticulocyte lysates. There is tremendous improvement in E. coli and wheat germ derived cell-free systems.

Further interest of biotechnology and biopharmaceutical companies in commercialization of these tools have led to growth of cell-free protein expression market. Surge in the research and development activities, increased interest in genomics and proteomics and demand for biologics are some of the key factors propelling the growth of cell-free protein expression market. However some hindrance while using cell-free systems is the low yield of target protein.

E. coli lysate is the most simple and well-established cell-free protein expression system for high yield production of prokaryotic proteins. In eukaryotic system most widely used is rabbit reticulocyte lysate (RRL) cell free protein expression system. It is more efficient and reduces the probability of error when compared with E. coli system.

White germ lysate is another eukaryotic expression system, which is popularly used and yields higher output compared to other eukaryotic system and used for large size protein expression method. Insect cell lysate is also used for large-size protein expression. Mammalian cell free protein expression method is anticipated to the be the most fast growing segment of cell protein expression market due to most preferred option for production of human protein. Rising demand for biologics and proteomics research and its application in human drug discovery is the driving factor for the growth mammalian cell free protein expression system market.

Currently, cell free protein expression is one of the most lucrative markets with a high adoption rate by the biopharmaceutical and biotechnological industry. It is being widely used in high-throughput functional proteomics and genomics.

Protein-protein interaction segments occupies the largest share of the cell free protein market expression. There is also significant growth observed in the research and development in protein production and generation of protein libraries contributing to the fast growth of protein- protein interaction segment.

Conventionally, batch expression was used for synthesis of target protein, as it is easy to handle, fast and reliable source for protein synthesis. Novel technique, continuous flow expression system is used for synthesis of both prokaryotic and eukaryotic proteins. Continuous-Exchange Cell-free (CECF) protein synthesis system yield better protein when compared with batch reaction. Thus, continuous flow expression system accounts for large share of cell-free protein expression market, and it expected to grow in the forecast period.

Cell-free protein expression has emerged as powerful novel technology that show continuous improvement and is ever expanding. Due to advance in CFPE, it possible from small scale to manufacturing scale protein synthesis, has inspired application in genomics and structural biology, personalized medicine and proteomic industrial application. At present, North America dominates the global cell free protein expression market followed by the Europe market. Huge investment in research and development, and rising demand of protein synthesis are the main drivers for the growth of cell protein fusion market. North America and Europe region occupies more than half of the global cell free protein expression market. Asia-Pacific is anticipated to be the fastest growing cell free protein expression market. Rise in research and development activities, increase in funding by government and biopharmaceutical & biotechnology companies coupled with surged demand of protein synthesis is the reason for growth in emerging market such as China and India.


Market Segmentation
Product

Application

Expression mode

Key Topics Covered:

1. Preface

2. Executive Summary

3. Cell Free Protein Expression Market: Business Outlook & Market Dynamics

4. Cell Free Protein Expression Market: By Product, 2020-2030, USD (Million)

5. Cell Free Protein Expression Market: By Application, 2020-2030, USD (Million)

6. Cell Free Protein Expression Market: By Expression mode, 2020-2030, USD (Million)

7. North America Cell Free Protein Expression Market, 2020-2030, USD (Million)

8. UK and European Union Cell Free Protein Expression Market, 2020-2030, USD (Million)

9. Asia Pacific Cell Free Protein Expression Market, 2020-2030, USD (Million)

10. Latin America Cell Free Protein Expression Market, 2020-2030, USD (Million)

11. Middle East and Africa Cell Free Protein Expression Market, 2020-2030, USD (Million)

12. Company Profile

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/4hr4j7

Media Contact: 

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

 

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg 

 

SOURCE Research and Markets


These press releases may also interest you

at 12:05
What's New: Intel and the University of California, San Diego (UC San Diego) announced today that they have been selected to join the Hardening Development Toolchains Against Emergent Execution Engines (HARDEN) program team for the Defense Advanced...

at 12:05
ZEGOCLOUD, a global cloud communication service provider, is upgrading from Real-Time Communication (RTC) to Real-Time Interaction (RTI). RTI encompasses all of the technological components required to create real-time interactive scenarios,...

at 12:05
PowerSchool , the leading provider of cloud-based software for K-12 education in North America, today announced that Paul Brook joins the company as Chief Customer Officer (CCO) beginning February 1, 2023. Brook brings over two-decades experience...

at 12:05
EngageSmart, Inc. , a leading provider of vertically tailored customer engagement software and integrated payments solutions, has been named one of Energage's 2023 Top Workplaces USA. The recognition comes via Energage, a purpose-driven organization...

at 12:05
Wind River®, a global leader in delivering software for mission-critical intelligent systems, has earned the nationally recognized 2023 Top Workplaces USA award. Wind River also showed leadership among its peers in the categories of innovation,...

at 12:05
Stemson Therapeutics, a private biotechnology company developing an iPSC-derived autologous cell therapy to regenerate healthy hair follicles, announced today that Kevin D'Amour, a veteran cell therapy development expert, has joined Stemson as Chief...



News published on 1 december 2022 at 05:30 and distributed by: